Discontinued — last reported Q1 '20
Johnson & Johnson Change in Other Liabilities decreased by 146.3% to -$270.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 109.8%, from $2.74B to -$270.00M.
Consistent increases may signal growing long-term commitments, while decreases show the company is paying down its non-current operational debts.
Adjusts net income for changes in long-term or non-current operating liabilities that do not fall into major categories....
Standard across large-cap industrials and tech firms to capture non-cash movements in long-term provisions.
cf_change_in_other_liabilities| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$902.00M | $110.00M | $6.33B | -$427.00M | -$2.64B | $2.74B | $359.00M | -$6.51B | $583.00M | -$270.00M |
| QoQ Change | — | +112.2% | >999% | -106.7% | -518.5% | +203.8% | -86.9% | <-999% | +109.0% | -146.3% |
| YoY Change | — | +112.2% | >999% | — | -141.7% | — | — | <-999% | +122.1% | -109.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.